Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.99 USD | -4.88% | -7.75% | +118.03% |
05-13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
05-08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.03% | 604M | |
+62.70% | 62.59B | |
-2.20% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.10% | 26.21B | |
-21.90% | 19.09B | |
+3.54% | 13.08B | |
+25.40% | 12.26B | |
+27.30% | 12.05B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Transcript : Mind Medicine Inc., Q2 2022 Earnings Call, Aug 11, 2022